A 62-year-old male heart transplant recipient with pro... [Chest. 2011] - PubMed

loading

Primary pancreatic non-Hodgkin's lymphoma in a renal transplant recipient. [Clin Nephrol. 1997]
Primary pancreatic non-Hodgkin's lymphoma in a renal transplant recipient.
Jamshed A, Rahal M, Khafaga Y, Taha I, Martin J, Linjawi T, Ezzat A. Clin Nephrol. 1997 Aug; 48(2):129-31.
Multiple hepatic nodules in a renal transplant recipient. [Clin Nephrol. 2009]
Multiple hepatic nodules in a renal transplant recipient.
Shu KH, Chai JW. Clin Nephrol. 2009 May; 71(5):579-83.
Review [Immunosuppression after heart and lung transplantation]. [Med Klin (Munich). 1997]
Review [Immunosuppression after heart and lung transplantation].
Wendler O, Schäfers HJ. Med Klin (Munich). 1997 Dec; 92 Suppl 5:3-7.
Induction immunosuppression with interleukin-2 receptor antibodies (basiliximab and daclizumab) in renal transplant recipients. [Transplant Proc. 2001]
Induction immunosuppression with interleukin-2 receptor antibodies (basiliximab and daclizumab) in renal transplant recipients.
Nair MP, Nampoory MR, Johny KV, Costandi JN, Abdulhalim M, El-Reshaid W, Al-Muzairai I, Ninan VT, Samhan M, Al-Mousawi M. Transplant Proc. 2001 Aug; 33(5):2767-9.
Review Immunosuppression in the sensitized heart transplant recipient. [Curr Opin Organ Transplant. 2010]
Review Immunosuppression in the sensitized heart transplant recipient.
Eckman PM. Curr Opin Organ Transplant. 2010 Oct; 15(5):650-6.

A 62-year-old male heart transplant recipient with progressive hypoxia.
A 62-year-old male heart transplant recipient with progressive hypoxia.
Chest. 2011 Apr ;139(4):954-7.

PubMed
Kinetics of activated thrombin-activatable fibrinolysis inhibitor (TAFIa)-cataly...
Kinetics of activated thrombin-activatable fibrinolysis inhibitor (TAFIa)-catalyzed cleavage of C-terminal lysine residues of fibrin degradation products and removal of plasminogen-binding sites.
J Biol Chem. 2011 Jun 3 ;286(22):19280-6. Epub 2011 Apr 5 .

PubMed
Evaluation of a PfHRP2 and a pLDH-based rapid diagnostic test for the diagnosis ...
Evaluation of a PfHRP2 and a pLDH-based rapid diagnostic test for the diagnosis of severe malaria in 2 populations of African children.
Clin Infect Dis. 2011 May ;52(9):1100-7.

PubMed
Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?
Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?
Clin Infect Dis. 2011 May ;52(9):e194-9.

PubMed
A placebo- and imipramine-controlled study of paroxetine.
A placebo- and imipramine-controlled study of paroxetine.
Psychopharmacol Bull. 1990 ;26(2):185-9.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed